Volume 29, issue 2, February 2022

ÉDITORIAL

Last advice before demolition (p.151-2)
Hakim Bécheur
Free Access

MINI-REVUES

Left-sided portal hypertension: A rare and fatal entity (p.155-63)
Pierre Mayer, Emanuele Felli, Aïna Venkatasamy
Free Access

Faecal immunochemical tests: Resembling a Swiss army knife (p.165-80)
Bernard Denis, Laurianne Plastaras, Callum G. Fraser
Free Access

New nutritional therapies in Crohn's disease. What can we learn from the paediatric experience? (p.183-90)
Rémi Duclaux-Loras, Nicolas Caron, Gilles Boschetti, Noël Peretti, Alain Lachaux
Free Access

Biliary duct tumors:What is the place of percutaneous biliary drainage? (p.192-202)
Badr Boutakioute, Raphaël Amar, Hajar El Mortaji, Dominique Cabral, Norbert Zhang, Robert Carlier, Frédérick Moryoussef, Mostafa El Hajjam
Free Access

Gastro-intestinal cancers and thrombosis: A new place for direct oral anticoagulants? (p.204-8)
Alice Ballerie, Alain Lescoat, Nicolas Belhomme, Marie Bismut, Pierre Guéret, Isabelle Gouin-Thibault, Patrick Jégo
Free Access

Biobetter: A bet for the future (p.209-12)
Thomas Bazin
Free Access

Dossier thématique : Corps étrangers digestifs

Pré-test QCM (p.215-6)

Free Access

Mise au point

Foreign bodies of the upper and lower digestive tract (p.217-25)
Vincent Quentin
Free Access

Cas clinique

Ingestion of battery: do not be quiet! (p.226-32)
Jérôme Viala
Free Access

Revue bibliographique

Better understand and manage foreign bodies in the upper digestive tract (p.233-6)
Lucille Quénéhervé
Free Access

Entretien avec l'expert

Management of foreign bodies in the gastrointestinal tract (p.237-41)
Xavier Dray
Free Access

Post-test QCM (p.242-4)

Free Access

CONCEPTS ET PRATIQUE

Finally a second line in cholangiocarcinoma with the ABC-06 study: Oxaliplatin after cisplatin, a winning team! (p.245-50)
Vincent Verdier, David Sefrioui
Free Access

IBD and infliximab: Is it the end of proactive therapeutic drug monitoring? (p.251-4)
Clément Bresteau, Mathieu Uzzan
Free Access

Metabolic syndrome and risk of pancreatic cancer: It's good to lose weight but it is better not to take it! (p.255-9)
Louis de Mestier, Vinciane Rebours
Free Access

Lanifibranor, a pan-PPAR agonist, improves NASH lesions (p.260-4)
Alexandre Pariente
Free Access

Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis : need for better results ! (p.265-8)
Antoine Debourdeau, Jérémie Jacques
Free Access

LECTURE

State of the art in Pancreatology (p.269-70)
Louis de Mestier
Free Access

BRÈVE D’HISTOIRE

The medical kit (p.271-4)
Jean-Louis Payen
Free Access

INJECTIONS DE RAPPEL

A retenir du n^o 1 janvier 2022 (p.275-8)

Free Access